Matrine Sodium Chloride Injection

This product can inhibit the occurrence of cachexia in tumor-bearing mice, inhibit the growth of cancer cells, and prolong the survival time of tumor-bearing mice by more than double. This product can inhibit the production of cachectin in tumor cells, and also inhibit the effect of cachectin on normal cells.

Matrine

This product is a colorless or almost colorless clear liquid.

This product is suitable for chronic active hepatitis and chronic persistent hepatitis.

Intravenous drip, once a day, 100 ml each time. The drip time should not be less than 40 minutes.

Patients have good tolerance to this product. Occasional adverse reactions include dizziness, nausea, vomiting, bitter taste in the mouth, diarrhea, upper abdominal discomfort or pain, and rare rash, chest tightness, and fever. In general, the symptoms can be relieved by themselves. Some patients may experience redness at the injection site or mild irritation pain at the injection site.

It is contraindicated for those who are allergic to this product.

Precautions for children: There is no information on the use of this drug in children. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women. Precautions for the elderly: Elderly patients should reduce the dosage or follow the doctor's advice.

Not yet clear.

Keep in a dark, airtight container in a cool place. Valid for 2 years.

100ml: matrine 80mg and sodium chloride 0.9g

24 months

Liaoning Yifan Pharmaceutical Co., Ltd.

• Founded in:

  2011-05-05

• Address:

  No. 67 Xianghuai Road, Benxi Economic and Technological Development Zone

• Tax NO.:

  9121050057425945XH

• Registered Funds:

  10 million yuan

• Email:

  Log in to view